Authors:
Bosi, E
Minelli, R
Bazzigaluppi, E
Salvi, M
Citation: E. Bosi et al., Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?, DIABET MED, 18(4), 2001, pp. 329-332
Authors:
Barera, G
Bazzigaluppi, E
Viscardi, M
Renzetti, F
Bianchi, C
Chiumello, G
Bosi, E
Citation: G. Barera et al., Macroamylasemia attributable to gluten-related amylase autoantibodies: A case report, PEDIATRICS, 107(6), 2001, pp. NIL_45-NIL_48
Authors:
Lampasona, V
Scirpoli, M
Bosi, E
Bonifacio, E
Citation: V. Lampasona et al., ICA12(SOX13) autoantibodies are unlikely to be a useful marker for pre-clinical Type I diabetes, DIABETOLOG, 44(2), 2001, pp. 267-267
Authors:
Betterle, C
Fabris, P
Zanchetta, R
Pedini, B
Tositti, G
Bosi, E
de Lalla, F
Citation: C. Betterle et al., Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection, DIABET CARE, 23(8), 2000, pp. 1177-1181
Authors:
Braghi, S
Bonifacio, E
Secchi, A
Di Carlo, V
Pozza, G
Bosi, E
Citation: S. Braghi et al., Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes, DIABETES, 49(2), 2000, pp. 218-224
Authors:
Bazzigaluppi, E
Lampasona, V
Barera, G
Venerando, A
Bianchi, C
Chiumello, G
Bonifacio, E
Bosi, E
Citation: E. Bazzigaluppi et al., Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease, J AUTOIMMUN, 12(1), 1999, pp. 51-56
Authors:
Bosi, E
Garancini, MP
Poggiali, F
Bonifacio, E
Gallus, G
Citation: E. Bosi et al., Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy, DIABETOLOG, 42(7), 1999, pp. 840-844